Duo Oncology
PrivateLast Round
Seed
Aug 7, 2025
Total Funding Raised
$9.45M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Duo Oncology operates in Healthcare & Life Sciences and is based in Pittsburgh, Pennsylvania. Its latest recorded funding round was a Seed round in August 2025.
Duo Oncology is a biotechnology company that develops tumor-responsive nanomedicines to treat difficult-to-target cancers.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Duo Oncology Comparables
Compare Duo Oncology with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Fulgent Pharma | 82% | |
| Pendrea Bio, Inc. | 79% | |
| Adcentrx Therapeutics | 73% |
For institutional investors. Book with your work email.
Duo Oncology Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Aug 7, 2025 | ||||
| Seed Round | Jun 2, 2025 | ||||
| Grant | Dec 12, 2024 | ||||
| Accelerator | Mar 21, 2024 | ||||
| Seed | Aug 7, 2023 | ||||
Grant | Apr 17, 2023 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Duo Oncology Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Cancer Institute | Grant |
| LifeX Ventures | Seed |
| LifeX Global | Seed |
| Innovation Works | Seed |
| Ulu Ventures | Seed |
| SeedFolio | Seed |
| NuFund | Seed |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 59% MoM.
- Aug 7, 2025
$3M round led by SeedFolio.
For institutional investors. Book with your work email.
Duo Oncology Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Duo Oncology's valuation, stock price, and market status.
Is Duo Oncology a public or private company?
Duo Oncology is a private company.
What is the current stock price of Duo Oncology?
Duo Oncology is a private company, so its shares have no public market price. Caplight tracks Duo Oncology's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Duo Oncology worth (valuation)?
Valuation information for Duo Oncology is not publicly available.
Can I buy Duo Oncology stock?
Duo Oncology shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Duo Oncology's last funding round?
Duo Oncology's most recent funding round was Seed on August 7, 2025.
Who are the main investors in Duo Oncology?
Key investors in Duo Oncology include SeedFolio.
Will Duo Oncology IPO soon?
No public IPO plans have been announced for Duo Oncology.
How can I track Duo Oncology secondary market activity?
Caplight tracks bids, offers, and trades in Duo Oncology's shares on secondary markets.